Elizabeth Rozek

CIK: 0001975022

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (42.9%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SGMT

Sagimet Biosciences Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

SGMT
Sagimet Biosciences Inc.
Jul 20, 2026
Sale(S)
Direct
10.5K shares at avg. $7.76$82K
SGMT
Sagimet Biosciences Inc.
May 28, 2026
Award(A)
Stock Option (Right to Buy)
Direct
100K shares-
SGMT
Sagimet Biosciences Inc.
Feb 19, 2026
Award(A)
Direct
44K shares-
SGMT
Sagimet Biosciences Inc.
Feb 10, 2026
Sale(S)
Direct
2.6K shares at avg. $5.36$14K
SGMT
Sagimet Biosciences Inc.
Nov 4, 2025
Award(A)
Direct
9.9K shares-
SGMT
Sagimet Biosciences Inc.
Jul 21, 2025
Sale(S)
Direct
10.8K shares at avg. $9.13$98K
SGMT
Sagimet Biosciences Inc.
Feb 6, 2025
Award(A)
Direct
34K shares-

		Type	Shares	Price		Ownership
Jul 20, 2026	SGMT Sagimet Biosciences Inc.	Sale(S)	10,545	$7.76	$81,832	Direct
May 28, 2026	SGMT Sagimet Biosciences Inc.	Award(A) Stock Option (Right to Buy)	100,000	-	-	Direct
Feb 19, 2026	SGMT Sagimet Biosciences Inc.	Award(A)	44,000	-	$0	Direct
Feb 10, 2026	SGMT Sagimet Biosciences Inc.	Sale(S)	2,622	$5.36	$14,054	Direct
Nov 4, 2025	SGMT Sagimet Biosciences Inc.	Award(A)	9,855	-	-	Direct
Jul 21, 2025	SGMT Sagimet Biosciences Inc.	Sale(S)	10,780	$9.13	$98,471	Direct
Feb 6, 2025	SGMT Sagimet Biosciences Inc.	Award(A)	34,000	-	-	Direct

1-7 of 7 transactions

About Rozek Elizabeth

Rozek Elizabeth (SEC CIK 0001975022) files insider reports with the SEC as Chief Legal & Admin. Officer of Sagimet Biosciences Inc. (SGMT).

Signal8 holds 7 ownership filings by Rozek Elizabeth, all Form 4s, filed between Feb 7, 2025 and Jul 22, 2026. Those filings report 7 transactions, from Feb 6, 2025 to Jul 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rozek Elizabeth's filings is in FOSTER CITY, CA.

Recent filings by Rozek Elizabeth

Jul 20, 2026: Open-market sale of SGMT shares (Form 4, code S).
May 28, 2026: Grant or award of SGMT derivative securities (Form 4, code A).
Feb 19, 2026: Grant or award of SGMT shares (Form 4, code A).
Feb 10, 2026: Open-market sale of SGMT shares (Form 4, code S).
Nov 4, 2025: Grant or award of SGMT shares (Form 4, code A).

Other insiders filing for Sagimet Biosciences Inc. (SGMT)

Kemble George, Director
Happel David, President & CEO
SEIDENBERG BETH C, Director
Hoelscher Paul W., Director
Jarrett Jennifer, Director
GRAMMER ELIZABETH A, Director

How to read Form 4 transaction codes